1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: INTERTECC, R21CA162718-01, NCT01554397
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LACC001, NCT00614211
|
|
3.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654709, RTOG-0724, NCT00980954
|
|
4.
|
Phase: Phase III Type: Tissue collection/Repository, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000670125, GOG-0263, NCT01101451
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-098, NCT01399658
|
|
6.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05-0977 / 201104019, NCT00359866
|
|
7.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-13419, NCI-2011-0098, NCT01375699
|
|
8.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2003-0529, NCT00394602
|
|
9.
|
Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: HM10390, P01CA116602, NCT00571415
|
|
10.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000646813, GOG-0244, NCT00956670
|
|
11.
|
Phase: No phase specified Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2008-0118, NCT01048853
|